Skip to content
ORF Genetics logo — Global leader in barley biotechnology

ORF Genetics

Global leader in barley biotechnology

Founded 2001 Iceland Iceland 25 employees Grant Total: $210.64M Biotechnology

General Information

Company Name ORF Genetics
Founded Year 2001
Location Iceland Iceland
Founders / Decision Makers
Team member Team member
Employees 25
Industries Biotechnology
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with ORF Genetics. To contact ORF Genetics, visit orfgenetics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ORF Genetics compare?

A PDF of ORF Genetics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ORF Genetics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ORF Genetics

ORF Genetics is a privately-owned Icelandic company founded in 2001. The company has established itself as a global leader in barley biotechnology, with a strong focus on developing innovative solutions for protein production. The company's unique expression system, Orfeus™, utilizes barley grain to produce recombinant proteins more efficiently and safely than traditional methods. ORF Genetics has successfully developed a diverse portfolio of growth factors for various markets including stem cell research, skincare, and cultivated meat. One of the company's notable ventures is ISOKINE™, which offers endotoxin-free growth factors and cytokines at lower list prices compared to market leaders, without compromising on bioactivity. Additionally, the development of BIOEFFECT™, a plant-based anti-aging skincare range, has gained significant traction, being used by over 30% of Icelandic women since its launch in 2010 and being retailed in premium stores such as Harrods and Bergdorf Goodman. The company's latest project, MESOKINE™, presents an innovative solution for the FoodTech industry by producing growth factors for cultivated meat, addressing the environmental and ethical challenges associated with the global meat industry. Notably, ORF Genetics operates in an eco-friendly greenhouse located in an Icelandic lava field, emphasizing its commitment to sustainable practices. In March 2013, the company received a ISK12.50M grant investment from the Technology Development Fund, signaling external validation and support for its pioneering work in biotechnology. ORF Genetics continues to drive innovation in protein production and expand its market impact across diverse industries.

Business keywords: Protein Expression, Growth Factors, Cytokines, Barley Biotechnology, Stem Cell Research, Skincare, Anti-aging, Cellular Agriculture, Clean Meat, FoodTech, Icelandic Biotech, Recombinant Proteins, Orfeus™ Expression System, Environmental Impact

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Grant ISK12.50M 1
Technology Development Fund
01 Mar 2013
Grant ISK12.50M 1
Technology Development Fund
01 Mar 2012
Grant ISK12.50M 1
Technology Development Fund
01 Mar 2011
Grant ISK75.00M 1
Technology Development Fund
01 Mar 2010
Grant ISK3.00M 1
Technology Development Fund
01 Mar 2009
Grant ISK20.00M 1
Technology Development Fund
01 Mar 2008
Grant ISK20.00M 1
Technology Development Fund
01 Mar 2007
Grant ISK28.64M 1
Technology Development Fund
01 Mar 2006
Grant ISK20.00M 1
Technology Development Fund
01 Mar 2005
Grant ISK6.50M 1
Technology Development Fund
01 Mar 2004

ORF Genetics Alternatives & Competitors

View All Alternatives
ORF Genetics vs

The future of recombinant protein bioproduction for Regenerative Medicine & Skincare.

Seed
31 employees
Biotechnology, Life Sciences
ORF Genetics vs
StemImmune LLC
StemImmune LLC United States

Humanized cytokines and Growth factors for your research and preclinical study. Save your money and...

3 employees
Biopharma, Biotechnology
ORF Genetics vs
Qkine
Qkine United Kingdom

High quality and novel growth factors for stem cell and organoid culture, regenerative medicine and...

Series B
40 employees
Biotechnology, Life Sciences

FAQ About ORF Genetics

Global leader in barley biotechnology
ORF Genetics was founded in 2001.
ORF Genetics is headquartered in Iceland.
ORF Genetics operates in Biotechnology. Its work centres on Protein Expression, Growth Factors, Cytokines and Barley Biotechnology.
ORF Genetics has approximately 25 employees.
ORF Genetics has completed 10 funding rounds, raising a total of $210.64M. The latest funding stage is Grant.
Top alternatives and competitors to ORF Genetics include Core Biogenesis, StemImmune LLC, Qkine, ProMab Biotechnologies, Inc., trenzyme GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ORF Genetics and Core Biogenesis are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ORF Genetics, https://bouncewatch.com/company/orf-genetics, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout